Tag:

Zostavax

Latest Headlines

Latest Headlines

Patients clamor for scarce Merck vaccine

FiercePharma | October 13, 2008
High demand for Merck's Zostavax shingles vaccine is causing shortages across the country. Doctors are

One up, two down for Merck's vaccines

FiercePharma | June 26, 2008
One out of three ain't bad? Out of a trio of Merck vaccine news today, one story was a clear thumbs-up for the company: Its

CDC backs wide use of Merck's Zostavax

FiercePharma | May 20, 2008
SPOTLIGHT: CDC backs wide use of Merck's Zostavax
Related Tags

Zostavax Press Releases

  • FDA Approves Zostavax Vaccine to Prevent Shingles in Individuals 50 to 59 Years of Age
  • In Investigational Study, ZOSTAVAX®, Merck's Shingles Vaccine, Reduced Incidence of Shingles in Adults Ages 50 to 59
Press Releases
  • Study: Once-Weekly Trulicity™ (dulaglutide) Provides Greater Blood Sugar Reduction Compared to Once-Daily Victoza® (liraglutide) in Japanese Patients after 52 weeks
  • Study: Once-Weekly Trulicity™ (dulaglutide) Provides Greater Blood Sugar Reduction Compared to Once-Daily Victoza® (liraglutide) in Japanese Patients after 52 weeks
  • Basal Insulin Peglispro Studies Demonstrate Superiority to Insulin Glargine Across Multiple Measures in People with Type 1 Diabetes
  • Basal Insulin Peglispro Studies Demonstrate Superiority to Insulin Glargine Across Multiple Measures in People with Type 1 Diabetes
  • Lilly's Basal Insulin Peglispro Shows Superiority to Insulin Glargine in Reducing HbA1c in People with Type 2 Diabetes
  • More Press Releases
Sponsored Links